CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Torii Pharmaceutical Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Torii Pharmaceutical Co Ltd
Torii Nihombashi Bldg.
3-4-1, Nihombashi Hon-cho
Phone: +81 332316811p:+81 332316811 CHUO-KU, TKY  103-8439  Japan Ticker: 45514551
Business Summary
TORII PHARMACEUTICAL CO., LTD. is mainly engaged in the manufacture and sale of pharmaceutical products. The Company’s main product categories include oral pruritus improving agents, proteolytic enzyme inhibitors, hyperkalemia improving agents, topical adrenocortical hormones, allergen immunotherapy for cedar pollinosis, allergen immunotherapy for mite allergy, active viable bacterial preparations, uterine contraction inhibitors in premature birth and others. The Company’s main products include Remitch, Riona tablets, Keixalate, Yulinome tablets, Antebate, Locoid, Zefnate, Sida Torengi pollen sublingual solution, Miticure mite sublingual tablet, Biosley, Magcent and others.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2022Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
6411 Insurance agents, brokers, and service
6531 Real estate agents and managers

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President, Chief Executive Officer, Representative Director GoichiMatsuda 57 3/1/2019 3/24/2017
Vice President, Representative Director NobumasaKondo 55 3/27/2024 3/1/2019
Managing Executive Officer, Leader of Medical Sales Group KatsunobuFujiwara 60 3/26/2020 6/1/2012
7 additional Officers and Directors records available in full report.

Business Names
Business Name
4551
Torii Pharmaceutical Co., Ltd.

General Information
Number of Employees: 583 (As of 12/31/2023)
Outstanding Shares: 28,111,342 (As of 9/30/2024)
Shareholders: 4,111
Stock Exchange: TYO
Fax Number: +81 352037333


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, December 3, 2024